Xofluza

Active Ingredient(s): Baloxavir Marboxil
FDA Approved: * October 24, 2018
Pharm Company: * GENENTECH INC
Category: Antiviral

Baloxavir marboxil (BXM), sold under the brand name Xofluza, is an antiviral medication for treatment of influenza A and influenza B flu.[2] It was approved for medical use both in Japan and in the United States in 2018,[4][5][6] and is taken as a single dose by mouth.[2] It may reduce the duration of flu symptoms by about a day, but is prone to selection of resistant mutants that render it ineffectual.[7&... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Xofluza 20 mg Oral Tablet, Film Coated
NDC: 50090-4102
Labeler:
A-s Medication Solutions
Xofluza 40 mg Oral Tablet, Film Coated
NDC: 50090-4104
Labeler:
A-s Medication Solutions
Xofluza 40 mg/ml Oral Granule, for Solution
NDC: 50242-583
Labeler:
Genentech, Inc.
Xofluza 20 mg Oral Tablet, Film Coated
NDC: 50242-828
Labeler:
Genentech, Inc
Xofluza 40 mg Oral Tablet, Film Coated
NDC: 50242-860
Labeler:
Genentech, Inc
Xofluza 80 mg Oral Tablet, Film Coated
NDC: 50242-877
Labeler:
Genentech, Inc.